imipenem, anhydrous has been researched along with Hepatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benbrika, S; Boukari, L; Fain, O; Kettaneh, A; Letellier, E; Stirnemann, J; Thomas, M | 1 |
| Kamiya, Y; Murata, Y; Narita, H; Suzuki, T; Tsuruga, N; Yura, J | 1 |
2 other study(ies) available for imipenem, anhydrous and Hepatitis
| Article | Year |
|---|---|
[A case of yersiniasis with multiple liver abscesses].
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hemochromatosis; Hepatitis; Humans; Imipenem; Liver Abscess; Male; Middle Aged; Ofloxacin; Radiography, Abdominal; Time Factors; Tomography, X-Ray Computed; Yersinia enterocolitica; Yersinia Infections | 2005 |
[Pharmacokinetics and clinical evaluation of imipenem/cilastatin sodium in pediatric surgery].
Topics: Bacterial Infections; Bile; Biliary Atresia; Chemical Phenomena; Chemistry; Cholangitis; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Half-Life; Hepatitis; Humans; Imipenem; Infant; Infant, Newborn; Male; Postoperative Complications; Premedication | 1988 |